Tim Hoey, PhD, Senior Vice President, Cancer Biology

Dr. Timothy Hoey is Sr. Vice President, Cancer Biology at OncoMed Pharmaceuticals. The Cancer Biology group is responsible for testing new drugs targeting cancer stem cells and translational research to discover biomarkers indicative of CSC frequency. Dr. Hoey previously served as Director, Biology Department at Amgen (San Francisco) and was responsible for characterization of oncogenes and development of drugs to target these oncogene products. Prior to this he was Director, Biology Department at Tularik, responsible for Cancer and Immunology research. Prior to joining Tularik, he performed post doctoral studies on the mechanisms of transcriptional regulation at UC Berkeley under Dr. Robert Tijian.

Dr. Hoey received a Ph.D. from Columbia University, where he conducted research on regulation of gene expression and embryonic development with Dr. Michael Levine. Dr. Hoey is co-inventor on several patents and co-author of over 50 scientific publications.